ID
34809
Descripción
TEST StudyStudy ID: 102863 Clinical Study ID: 102863 Study Title: A randomized, open-label, two-period, period-balanced, crossover study with three parallel groups to evaluate the relative bioavailability of single oral doses of SB 497115-GR phase III tablets [50 mg, 75 mg, 100 mg] compared to SB-497115-GR phase II tablets [25 mg and 50 mg] in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Trade Name: Eltrombopag Study Indication: Thrombocytopenia
Palabras clave
Versiones (1)
- 30/1/19 30/1/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
30 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Relative Bioavailability of SB 497115-GR phase III tablets compared to SB-497115-GR phase II tablets 102863
PGx-Pharmacogenetic Research Form
- StudyEvent: ODM
Descripción
Consent for PGx-Pharmacogenetic Research
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0021430
Descripción
Pharmacogenetic Test, Informed Consent
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
Descripción
Pharmacogenetic Test, Informed Consent, Date in time
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0011008
Descripción
Pharmacogenetic Test, Informed Consent, Indication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0031325
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0392360
Descripción
Blood Sample Collection (DNA)
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0005834
- UMLS CUI-3
- C0012854
Descripción
Pharmacogenetic Tests, Collection of blood specimen for laboratory procedure
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0005834
Descripción
Pharmacogenetic Tests, Collection of blood specimen for laboratory procedure, Date in time
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0005834
- UMLS CUI [1,3]
- C0011008
Descripción
Withdrawal of Consent
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C1707492
Descripción
Blood Sample Destruction
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0178913
- UMLS CUI-3
- C1948029
Descripción
Pharmacogenetic Test, Blood Specimen, Destruction, Request
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C1272683
Descripción
Pharmacogenetic Test, Blood Specimen, Destruction, Indication
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C3146298
Similar models
PGx-Pharmacogenetic Research Form
- StudyEvent: ODM
C0021430 (UMLS CUI-2)
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0005834 (UMLS CUI-2)
C0012854 (UMLS CUI-3)
C0005834 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1707492 (UMLS CUI-2)
C1707492 (UMLS CUI [1,2])
C0178913 (UMLS CUI-2)
C1948029 (UMLS CUI-3)
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,4])